---
title: "Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291466220.md"
description: "Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past five years with an annualized return of 28.89%, exceeding the market by 17.4%. With a current market cap of $8.66 billion, a $100 investment made five years ago would now be worth $355.78, highlighting the power of compounded returns."
datetime: "2026-07-01T21:30:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291466220.md)
  - [en](https://longbridge.com/en/news/291466220.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291466220.md)
---

# Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an annualized basis producing an average annual return of 28.89%. Currently, Hims & Hers Health has a market capitalization of $8.66 billion.

**Buying $100 In HIMS:** If an investor had bought $100 of HIMS stock 5 years ago, it would be worth **$355.78** today based on a price of $37.41 for HIMS at the time of writing.

### Hims & Hers Health’s Performance Over Last 5 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/07/01/2757fc836dae40e224280c5dca539256.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

_This article was generated by Benzinga's automated content engine and reviewed by an editor._

### Related Stocks

- [HIMS.US](https://longbridge.com/en/quote/HIMS.US.md)
- [HIMY.US](https://longbridge.com/en/quote/HIMY.US.md)
- [HIMZ.US](https://longbridge.com/en/quote/HIMZ.US.md)
- [HIYY.US](https://longbridge.com/en/quote/HIYY.US.md)

## Related News & Research

- [YieldMax HIMS Option Income Strategy ETF announces weekly distribution of $0.3403](https://longbridge.com/en/news/292098366.md)
- [Hims & Hers (HIMS) Stock Still Has Upside, but Risks Persist](https://longbridge.com/en/news/292189126.md)
- [Hims & Hers CFO Oluyemi Okupe disposes of 7,163 common shares for $261,540.56](https://longbridge.com/en/news/291973606.md)
- [Hims & Hers Health’s Peptide Opportunity Tempered By FDA Recommendation, Says Analyst](https://longbridge.com/en/news/291445761.md)
- [Top Hims & Hers Executive Makes Major Move With Company Stock](https://longbridge.com/en/news/290641802.md)